Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 7 (3) , 597-618
Abstract
No abstract availableKeywords
Funding Information
- Swedish Research Council
- European Foundation for the Study of Diabetes
- West Sweden Avtal om Läkarutbildning och Forskning (ALF) Program
- Novo Nordisk Foundation
- Swedish Heart-Lung Foundation
- Torsten Söderbergs Foundation
- Diabetes Wellness Network Sweden
- Swedish Diabetes Foundation
- Royal Society of Arts and Sciences in Gothenburg
- Wiberg Foundation
- Adlerbert Research Foundation
- I. Hultman Foundation
- S. and E. Goljes Foundation
- F. Neubergh Foundation
- N. Svarts foundation
- L. and J. Grönberǵs Foundation
- I.-B. and A. Lundbergs Research Foundation
This publication has 48 references indexed in Scilit:
- Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a high‐fat dietThe FASEB Journal, 2013
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosisNature Reviews Gastroenterology & Hepatology, 2013
- Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisWorld Journal of Gastroenterology, 2012
- Liver-Specific β-Catenin Knockout Mice Exhibit Defective Bile Acid and Cholesterol Homeostasis and Increased Susceptibility to Diet-Induced SteatohepatitisThe American Journal of Pathology, 2010
- Short Antisense Oligonucleotides with Novel 2′−4′ Conformationaly Restricted Nucleoside Analogues Show Improved Potency without Increased Toxicity in AnimalsJournal of Medicinal Chemistry, 2008
- Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2Journal of Clinical Investigation, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- YSK1 is activated by the Golgi matrix protein GM130 and plays a role in cell migration through its substrate 14-3-3ζJournal of Cell Biology, 2004
- Antibodies Against the Hepatic Asialoglycoprotein Receptor Perfused In Situ Preferentially Attach to Periportal Liver Cells in the RatHepatology, 1990
- Heterogeneous acinar localization of the asialoglycoprotein internalization system in rat hepatocytesHepatology, 1988